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Background: Glaucoma is a progressive optic neuropathy and a leading cause of blindness. Neural losses from
glaucoma are irreversible, and so the aim of glaucoma treatment is to slow progression and minimize the risk of
further damage. Functional improvement with treatment is not expected. We report the case of a patient who
experienced a significant improvement in vision following glaucoma surgery and review the literature regarding
this phenomenon.
Case presentation: A 64-year old male presented with a 13-month history of gradual vision loss in the right eye to
the extent that he could only perceive hand movements. His intraocular pressure (IOP) measured 50 mmHg and he
was found to have advanced primary open angle glaucoma. Medical treatment was commenced and he underwent a
successful right Mitomycin C-augmented trabeculectomy. Unexpectedly he experienced marked improvement in vision
post-operatively, with improvements maintained through six months of follow-up. At his most recent visit visual acuity
was 6/18 in the affected eye. Although the mechanism of improved vision cannot be proven it is likely that successful
lowering of IOP resulted in some reversal of retinal ganglion cell dysfunction. Important factors may have included his
relatively young age, high IOP and short duration of symptoms.
Conclusion: Although rare, functional improvements may occur following trabeculectomy. Glaucoma surgery should
be offered early to those with advanced disease, and considered even in those with reduced visual acuity.
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Glaucoma is characterized by progressive optic nerve de-
generation, evident clinically as structural changes to the
optic nerve head and corresponding loss of visual field
[1]. The pathogenesis is not fully understood but it is
thought to involve a heterogeneous group of patho-
logical processes that share the final common pathway
of progressive death of retinal ganglion cells and their
axons [2]. Glaucomatous damage is deemed irreversible;
therefore the optimal management currently depends on
early detection and treatment to minimize the risk of
progression and development of visual loss.
The first line treatment for glaucoma has traditionally
consisted of medical management with topical intraocu-
lar pressure lowering agents. However, recent guidance,
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unless otherwise stated.of Clinical Excellence (NICE) stipulate that, for patients
with advanced disease at presentation, surgery may be
an appropriate first line therapy [3]. The aim of early
surgery is to reduce the risk of further deterioration in
visual function, as improvement in vision following glau-
coma surgery is not expected. There is however, some
evidence that retinal ganglion cells damaged by glau-
coma might undergo a period of reversible dysfunction
preceding cell death [4,5]. Furthermore, reversible changes
in optic nerve head morphology have been reported fol-
lowing reductions of intraocular pressure [6-9]. These ob-
servations suggest that certain structural and functional
improvements may in fact be possible in some patients.
The aim of the current article is to 1) report the case
of a patient with advanced glaucoma at initial presenta-
tion that demonstrated marked improvement in visual
acuity following reduction in intraocular pressure with
trabeculectomy, and 2) to critically appraise the published
literature as to whether functional improvement is pos-
sible following glaucoma surgery.ral. This is an Open Access article distributed under the terms of the Creative
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A 64-year-old university professor presented to our facil-
ity complaining of a 13-month history of progressive
visual loss in his right eye. There was no associated
headache or ocular pain and he had no other symptoms
of note. He had no previous history of ocular problems,
although he had not attended for an eye examination for
more than ten years. The patient’s past medical history
was significant for bladder cancer managed with surgery
and chemotherapy twelve years ago. He had no history
of previous ocular surgery or trauma and was not using
any systemic medications, including corticosteroids. There
was a positive family history of glaucoma, with the pa-
tient’s older sister being diagnosed at age 52, although she
had not required surgery or developed significant visual
impairment.
On examination, best-corrected visual acuity was hand
movements in the right eye, and 6/6 in the left. There
was no injection of the conjunctivae; corneas were clear
and anterior chambers deep and quiet. Both pupils were
round and symmetrical in size, however there was a
right relative afferent pupillary defect. Goldman applana-
tion tonometry revealed a very high intraocular pressure
(IOP) in both eyes, measuring 50 mmHg in the right
and 48 mmHg in the left. Central corneal thickness was
596 μm in the right eye and 597 μm in the left. Refract-
ive error measured only +0.50 diopter sphere in both
eyes. Gonioscopy demonstrated wide-open angles bilat-
erally, the trabecular meshwork was heavily pigmented
but there were no iris transillumination defects. On di-
lated fundal examination there was evidence of advanced
glaucomatous excavation of both optic nerve heads, par-
ticularly severe in the right eye, where there was almost
complete loss of the neuroretinal rim (Figure 1A). Op-
tical coherence tomography (OCT) showed significant
thinning of the retinal nerve fiber layer (RNFL) in both
eyes, again worse in the right, with average RNFL thick-
nesses of 41.28 μm in the right eye and 75.11 μm in the
left (Figure 1B). Standard automated perimetry was not
possible in the right eye due to the poor visual acuity,
but in the left eye was reliable with a superonasal defect
and mean deviation of -6.54 dB (Figure 1C).
A diagnosis of advanced primary open angle glaucoma
was made and the patient was commenced on topical
latanoprost and brinzolamide to both eyes. After 24 hours
IOPs had decreased to 28 mmHg (right eye) and 21 mmHg
(left eye). Visual acuity had improved to 6/60 in the right
eye, and 6/5 in the left eye. Although there had been a
good percentage reduction in IOP with medication, due to
the advanced glaucomatous damage a lower target pres-
sure was required and the decision was made to proceed
with Mitomycin C-augmented trabeculectomy to the right
eye. Surgery was performed four weeks after presentation.
During surgery the eye was treated with 0.2 mg/mlMitomycin C (Kyowa Hakko Kirin Co, Ltd., Tokyo, Japan)
for 3 minutes, and 3 10-0 nylon releasable sutures were
used to secure the scleral flap. There were no complica-
tions noted and at day one post-operative review, IOP in
the right eye was 30 mmHg, decreasing to 10 mmHg with
gentle ocular massage. The patient was prescribed topical
dexamethasone 0.1% 2 hourly during daytime hours and
chloramphenicol four times per day to the right eye.
Over the next 2 to 3 weeks IOP was gradually lowered
through loosening of the releasable sutures and at the
4 week postoperative review was 9 mmHg. Surprisingly,
the patient reported a gradual improvement in vision in
the right eye since surgery, and at the 4 week visit the
best-corrected visual acuity had improved to 6/18. The
reduction in IOP and improvement in visual acuity has
subsequently been maintained over six months of follow-
up. During this period, the patient also reported a subject-
ive amelioration of vision. Fundal photographs, OCT and
standard automated perimetry were repeated six months
following surgery and are shown in Figure 2. Although
there was an improvement in vision, structural parame-
ters in the right eye appeared unchanged with no change
in neuroretinal rim appearance and average RNFL thick-
ness in the right eye measuring 39.18 μm at most recent
follow up.
Discussion
The patient described in this case had severe glaucomat-
ous damage at presentation, evident from the marked
loss of neural tissue seen on optic disc examination, the
presence of extreme thinning of RNFL on OCT, and the
severe functional deficit, with a visual acuity of only
hand movements and a relative afferent pupillary defect.
Such severe disease at presentation conveys a poor prog-
nosis and requires a low target pressure to minimize the
risk of visual loss. Surgery was offered with the sole aim
of preventing loss of remaining vision and with no expect-
ation for visual recovery. Surprisingly, lowering of IOP re-
sulted in a dramatic improvement in visual function.
Improvements in structural measurements are widely
appreciated to occur following successful reduction in
intraocular pressure with glaucoma surgery. For ex-
ample, Kotecha and colleagues have shown using con-
focal scanning laser ophthalmoscopy that reversal in disc
cupping can occur following trabeculectomy [10]. In a
series of 22 eyes from 20 patients evaluated using spec-
tral domain OCT, Russo and colleagues have demon-
strated significant decreases in cup depth following
trabeculectomy at both 1 week and 1 month postopera-
tively [11]. Increases in RNFL thickness measurements
are less widely reported. However, in a small series of 38
eyes of 31 patients with glaucoma, Aydin and colleagues
found a significant increase in circumpapillary RNFL
thickness following glaucoma surgery. 31 of 38 eyes had
Figure 1 Investigations conducted at presentation. (A) Fundoscopic examination showing advanced glaucomatous excavation bilaterally.
(B) Optical coherence tomography report demonstrating asymmetric RNFL thinning more pronounced in the right eye. (C) Left eye pattern
deviation plot from standard automated perimetry.
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Figure 2 Investigations conducted at 6 months follow-up (post-trabeculectomy). (A) Fundoscopic examination. (B) Optical coherence
tomography. (C) Right eye grey scale and left eye pattern deviation plots from standard automated perimetry.
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surgery, with a mean increase of 12.6 μm [12]. In fact
there is a considerable body of evidence demonstratingreversal of structural glaucomatous damage following
pressure-lowering surgical interventions, with apparent re-
versal of structural changes especially common in younger
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coma [13-17].
In contrast to the improvements observed in structural
measurements, evidence for functional improvement fol-
lowing glaucoma surgery is scarce. Leung and colleagues
described a single case of a patient with juvenile open-
angle glaucoma who recovered from an inferotemporal
visual field defect following trabeculectomy [18]. How-
ever, due to the variability inherent in visual field testing
detecting genuine improvement may be challenging.
Clinical interventions in glaucoma are generally judged
on their capacity to reduce the incidence of progression
of visual field endpoints, however, few studies have in-
vestigated whether improvements in visual function
might occur. One exception was the Otago Glaucoma
Surgery Outcome Study, which was a prospective case
series including 841 eyes of 607 patients with primary
open or closed angle glaucoma. Patients were treated
with trabeculectomy and followed for an average of
7.5 years. Visual acuity was tested at each visit and cate-
gorised as ≥6/9, <6/9 but >6/120, or ≥6/120, with im-
provement in visual acuity defined by an improvement
in class. The results demonstrated 151 of 841 eyes (18%)
had an improvement in vision following trabeculectomy
[19]. However, a limitation of this study was that 23% of
eyes with improvement in vision underwent concurrent
cataract extraction. In future surgical glaucoma studies it
would be interesting to determine the true incidence of
visual improvement.
It is important to consider the possible mechanism of
visual improvement in our patient. Although the defin-
ing histological feature of glaucoma is loss of retinal gan-
glion cells and their axons, the exact mechanism of
retinal ganglion cell death is not known. Retinal ganglion
cell death is believed to be biphasic; with a primary in-
sult initiating damage that provokes a cascade of events,
in turn creating a noxious environment that envelops
retinal ganglion cells, resulting in secondary cell degen-
eration [20]. Increased IOP and vascular deregulation
may contribute to the primary insult, obstructing axo-
plasmic flow and altering microcirculation in the optic
nerve. The secondary cascade is likely to involve excito-
toxic damage from the accumulation of glutamate, in-
creased intracellular calcium and resultant retinal ganglion
cell apoptosis [21].
Once apoptosis has occurred it is difficult to conceive
how visual function might improve, however, Swanson
and colleagues have proposed that retinal ganglion cells
might undergo a period of reversible dysfunction pre-
ceding apoptosis [22]. Evidence for this theory largely
comes from primate studies of experimental glaucoma.
In one study involving rhesus monkeys with unilateral
laser-induced experimental glaucoma, Harwerth and col-
leagues found reductions in visual field sensitivity couldbe present without apparent retinal ganglion cell loss on
histology [23,24]. Marx and colleagues examined flash
and pattern electroretinograms (PERG) in experimental
glaucoma [25,26]. The results showed that 50% reduc-
tions in PERG amplitude could occur in the absence of
observable glaucomatous optic disc changes. A limita-
tion of these studies is that they utilized animal models
of experimental glaucoma, in which glaucoma was rap-
idly induced. However, similar findings have been re-
ported in humans. For example, Ventura and colleagues
conducted a study of 84 patients with suspected glau-
coma and found a disproportionate reduction in PERG
amplitude compared to RNFL thickness, supporting the
concept that retinal ganglion cell dysfunction might pre-
cede permanent structural and functional changes [27].
The possibility of reversible RGC dysfunction has
driven interest in the concepts of neuroprotection, neu-
roregeneration and neuroenhancement. Neuroprotection
may allow preservation of retinal ganglion cells by halt-
ing the secondary cascade of glaucoma pathogenesis
[28-30]. Neuroregeneration is the process of promoting
the rebuilding of optic nerve axons and neuroenhance-
ment is treatment to provide short-term improvements
in function of surviving retinal ganglion cells.
The patient described in the present case presented
with a visual acuity of hand movements, yet recovered
6/18 vision following trabeculectomy. In this case surgical
reduction in IOP is likely to have had a neuroprotective ef-
fect, increasing the chance of preserving remaining retinal
ganglion cells. However, the improvement in visual func-
tion is likely to have been due to a neuroenhancing effect
of IOP reduction. Although the mechanism of improved
vision cannot be proved, it is probable the reduction in
IOP from the very high preoperative levels may have im-
proved retinal ganglion cells function through restoration
of axoplasmic flow and improved microcirculation to the
optic nerve. Contributing factors may have included the
patient’s relatively young age, high IOP and short duration
of symptoms.
It is also important to acknowledge that the patient
may have had an improvement in vision without surgery,
and had already experienced some improvement in vi-
sion with IOP reduction with medical treatment. Unfor-
tunately, due to the severe glaucomatous in the right
eye, the visual prognosis remains poor.
Conclusion
In conclusion, although glaucomatous damage is deemed
irreversible, our patient experienced a significant im-
provement in vision following successful reduction in
IOP. This patient’s experience is a single case, yet it con-
tributes to the evidence that filtration surgery may lead
to functional as well as structural improvement in some
patients. This may be an important consideration for
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improvements in vision with glaucoma surgery. For ex-
ample, although the Advanced Glaucoma Intervention
Study (AGIS) provided evidence that trabeculectomy is
an effective procedure for lowering IOP and reducing
the risk of visual field progression in advanced glau-
coma, the study did not report whether there was im-
provement in vision in any patients following surgery
[31]. This case also supports the recommendation that
early surgery should be considered in patients presenting
with advanced glaucomatous damage.
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